Daiwa upgraded Gilead (GILD) to Outperform from Neutral with a $128 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead Sciences Appoints New Senior Vice President
- Gilead Sciences’ Phase 3 Study on Triple Negative Breast Cancer: A Potential Game-Changer?
- Gilead Sciences: Hold Rating Amidst Strong HIV Performance and Limited Growth Prospects
- Gilead Sciences: Strong Q2 Performance and Promising Yeztugo Launch Support Buy Rating
- Gilead Sciences’ Earnings Call Highlights Growth and Strategic Advances